Total Payments
$3,651
2022 Payments
$726.36
Companies
23
Transactions
166
Medicare Patients
2,434
Medicare Billing
$162,132
Payment Breakdown by Category
Food & Beverage$3,186 (87.3%)
Education$465.14 (12.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,186 | 142 | 87.3% |
| Education | $465.14 | 24 | 12.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $827.16 | 40 | $0 (2022) |
| NeoTract Inc. | $668.25 | 21 | $0 (2020) |
| Teleflex LLC | $550.07 | 7 | $0 (2022) |
| PFIZER INC. | $382.22 | 31 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $315.43 | 18 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $143.04 | 8 | $0 (2019) |
| UroGen Pharma, Inc. | $110.08 | 4 | $0 (2022) |
| Avadel Specialty Pharmaceuticals, LLC | $105.34 | 7 | $0 (2018) |
| Janssen Biotech, Inc. | $79.75 | 4 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $68.44 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $726.36 | 27 | Astellas Pharma US Inc ($244.84) |
| 2021 | $548.62 | 14 | Teleflex LLC ($345.09) |
| 2020 | $220.59 | 10 | NeoTract Inc. ($176.29) |
| 2019 | $820.72 | 33 | NeoTract Inc. ($389.61) |
| 2018 | $856.34 | 54 | PFIZER INC. ($192.52) |
| 2017 | $478.69 | 28 | Astellas Pharma US Inc ($184.51) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Interventional Urology | ||||||
| 11/21/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $41.36 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/24/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Urology | ||||||
| 10/17/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Gastroenterology | ||||||
| 10/10/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Urology | ||||||
| 09/19/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Oncology | ||||||
| 09/12/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diagnostic Imaging | ||||||
| 08/17/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Oncology | ||||||
| 07/26/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $13.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/30/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/16/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: Oncology | ||||||
| 05/11/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $139.16 | General |
| Category: Interventional Urology | ||||||
| 05/09/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Urology | ||||||
| 05/03/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Oncology | ||||||
| 04/18/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 03/24/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Interventional Urology | ||||||
| 03/16/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 03/16/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.00 | General |
| 02/28/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Oncology | ||||||
| 02/14/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Urology | ||||||
| 02/02/2022 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Interventional Urology | ||||||
| 01/24/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Oncology | ||||||
| 01/20/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 518 | 684 | $112,161 | $23,109 |
| 2021 | 16 | 884 | 1,142 | $171,123 | $33,252 |
| 2020 | 19 | 1,032 | 1,480 | $485,855 | $105,771 |
Total Patients
2,434
Total Services
3,306
Medicare Billing
$162,132
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 204 | $35,700 | $11,855 | 33.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 21 | 28 | $25,536 | $5,151 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $6,993 | $2,473 | 35.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 12 | 12 | $14,328 | $1,315 | 9.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 175 | 235 | $8,393 | $733.24 | 8.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,926 | $675.17 | 23.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 70 | 82 | $15,498 | $555.58 | 3.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 15 | 18 | $2,225 | $313.77 | 14.1% |
| 81005 | Analysis of urine, except immunoassays | Office | 2022 | 15 | 15 | $510.00 | $32.03 | 6.3% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2022 | 12 | 52 | $52.00 | $5.65 | 10.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 161 | 190 | $32,627 | $11,183 | 34.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 37 | 46 | $41,217 | $7,662 | 18.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 68 | $17,742 | $5,503 | 31.0% |
| 76872 | Ultrasound of pelvic region through rectum | Office | 2021 | 16 | 16 | $18,736 | $1,742 | 9.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $5,448 | $1,599 | 29.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 67 | 85 | $8,350 | $1,545 | 18.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 217 | 294 | $7,785 | $1,182 | 15.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 121 | 145 | $26,803 | $965.63 | 3.6% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2021 | 21 | 30 | $2,659 | $551.70 | 20.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 18 | $2,503 | $505.89 | 20.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 67 | 83 | $3,105 | $246.00 | 7.9% |
| 87086 | Bacterial colony count, urine | Office | 2021 | 16 | 25 | $997.88 | $201.75 | 20.2% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2021 | 11 | 16 | $746.78 | $138.40 | 18.5% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2021 | 11 | 16 | $1,275 | $129.28 | 10.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 20 | 29 | $751.36 | $91.93 | 12.2% |
About Dr. Peter Slocum, MD
Dr. Peter Slocum, MD is a Urology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891788113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Slocum, MD has received a total of $3,651 in payments from pharmaceutical and medical device companies, with $726.36 received in 2022. These payments were reported across 166 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,186).
As a Medicare-enrolled provider, Slocum has provided services to 2,434 Medicare beneficiaries, totaling 3,306 services with total Medicare billing of $162,132. Data is available for 3 years (2020–2022), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Milwaukee, WI
- Active Since 08/23/2005
- Last Updated 11/09/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1891788113
Products in Payments
- UroLift (Device) $668.25
- XTANDI (Drug) $561.47
- UroLift System (Device) $364.36
- XIAFLEX (Biological) $315.43
- Myrbetriq (Drug) $197.05
- UROLIFT (Device) $185.71
- MYRBETRIQ (Drug) $135.19
- TOVIAZ (Drug) $112.15
- JELMYTO (Drug) $110.08
- Noctiva (Drug) $105.34
- FIRMAGON (Drug) $104.32
- ERLEADA (Drug) $79.75
- PROVENGE (Drug) $68.44
- ELIGARD (Drug) $65.04
- Xtandi (Drug) $56.30
- NOCDURNA (Drug) $38.72
- Lupron (Drug) $17.96
- Axumin (Drug) $17.35
- TRULANCE (Drug) $17.12
- Nubeqa (Drug) $16.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Milwaukee
Dr. Amy Guise, Md, MD
Urology — Payments: $121,206
Urology $121,206
Dr. Robert Oconnor, Md, MD
Urology — Payments: $32,733
Urology $32,733
Dr. Mark Waples, Md, MD
Urology — Payments: $15,342
Urology $15,342
Dr. Matthew Johnson, Md, MD
Urology — Payments: $10,827
Urology $10,827
Dr. Peter Leonovicz, Md, MD
Urology — Payments: $9,568
Urology $9,568
Graham Machen, M.d, M.D
Urology — Payments: $9,226
Urology $9,226